The North America Pharmaceutical Drying Equipment Market was valued at $1485.3 Million in 2024 and projected to reach to $2073 Million by 2029, representing a compound annual growth rate of 6.9%. The North America pharmaceutical drying equipment market is poised for steady growth, expanding from $1,485.3 million in 2024 to $2,073.0 million by 2029 at a 6.9% CAGR.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America commands a significant share of the global pharmaceutical drying equipment market, driven by the region's advanced manufacturing capabilities and dominance of major pharmaceutical and biopharmaceutical companies headquartered in the US and Canada.
Stringent FDA and Health Canada regulations mandate cutting-edge drying technologies for pharmaceutical production, compelling manufacturers to invest in state-of-the-art equipment that meets the highest quality and safety standards.
Significant growth in biologics, monoclonal antibodies, and vaccine production across North America is accelerating demand for specialized drying equipment capable of handling sensitive biopharmaceutical formulations.
Continuous investment in pharmaceutical manufacturing infrastructure modernization and facility expansions across the US and Canada supports robust demand for advanced drying technologies through 2029.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | FREEZE DRYERS (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 7.1% from 2024 to 2029 |
| Largest Segment | PHARMACEUTICAL AND BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 5.81 (2024) |
| Revenue Forecast (Billions) | ~USD 8.18 (2029) |
| Segments Covered | Type, Scale Of Operation, End User |
3 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| US | USD 676.69 Million |
| Canada | USD 72.94 Million |
North America's pharmaceutical drying equipment market is estimated at $1,485.3 million in 2024 and is forecast to reach $2,073.0 million by 2029.
North America's pharmaceutical drying equipment market is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2029.
North America's market growth is driven by increased biopharmaceutical production, vaccine manufacturing expansion, stringent FDA and Health Canada regulations, and the adoption of advanced freeze-drying and spray-drying technologies.
Freeze-drying and spray-drying technologies are the most in-demand in North America, particularly for biologics, vaccines, and complex pharmaceutical formulations requiring high precision and regulatory compliance.
North America's stringent FDA and Health Canada regulations mandate advanced quality control, process validation, and equipment compliance, driving continuous modernization and replacement of drying equipment across the region.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study , International Diabetes Federation (IDF), and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global pharmaceutical drying equipment market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the pharmaceutical drying equipment market. The primary sources from the demand side include pharmaceutical, biopharmaceutical companies, contract development and manufacturing organizations, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pharmaceutical drying equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global pharmaceutical drying equipment market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global pharmaceutical drying equipment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Pharmaceutical drying equipment is used to remove solvents, such as water, from drug formulations through the application of heat. This process ensures the stability and efficacy of the final product by preventing chemical and microbiological deterioration. Common methods include air drying, vacuum drying, freeze-drying, and spray drying. These methods are crucial in both research and large-scale manufacturing to produce dry solid masses or powders, maintaining the quality and safety of active pharmaceutical ingredients (APIs).
Full forecast, segment splits, and company analysis for all Pharmaceutical Drying Equipment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report